Definitive Healthcare (DH) Stock Forecast & Price Target $0.85 +0.03 (+3.91%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$0.90 +0.04 (+5.14%) As of 05/22/2026 06:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Definitive Healthcare - Analysts' Recommendations and Stock Price Forecast (2026) How MarketBeat Calculates Price Target and Consensus Rating Consensus Rating HoldBased on 8 Analyst RatingsSell3Hold3Buy2 Based on 8 Wall Street analysts who have issued ratings for Definitive Healthcare in the last 12 months, the stock has a consensus rating of "Hold." Out of the 8 analysts, 3 have given a sell rating, 3 have given a hold rating, 1 has given a buy rating, and 1 has given a strong buy rating for DH. Consensus Price Target $2.77224.65% Upside According to the 8 analysts' twelve-month price targets for Definitive Healthcare, the average price target is $2.77. The highest price target for DH is $6.00, while the lowest price target for DH is $1.00. The average price target represents a forecasted upside of 224.65% from the current price of $0.85. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Get the Latest News and Ratings for DH and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Definitive Healthcare and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DH Analyst Ratings Over TimeTypeCurrent Forecast5/23/25 to 5/23/261 Month Ago4/23/25 to 4/23/263 Months Ago2/22/25 to 2/22/261 Year Ago5/23/24 to 5/23/25Strong Buy1 Strong Buy rating(s)1 Strong Buy rating(s)1 Strong Buy rating(s)0 Strong Buy rating(s)Buy1 Buy rating(s)1 Buy rating(s)1 Buy rating(s)1 Buy rating(s)Hold3 Hold rating(s)4 Hold rating(s)3 Hold rating(s)7 Hold rating(s)Sell3 Sell rating(s)4 Sell rating(s)3 Sell rating(s)2 Sell rating(s)Consensus Price Target$2.77$3.27$3.94$5.10Forecasted Upside224.65% Upside227.21% Upside161.04% Upside68.87% UpsideConsensus RatingHoldReduceHoldReduce DH Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History DH Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Definitive Healthcare Stock vs. The CompetitionTypeDefinitive HealthcareComputer and Technology CompaniesBroader MarketConsensus Rating Score 2.00 2.29 2.52Consensus RatingHoldHoldModerate BuyPredicted Upside224.65% Upside156.59% Upside15.03% UpsideNews Sentiment RatingPositive NewsSee Recent DH NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails5/8/2026 Robert W. Baird3 of 5 stars Set Target$1.10+16.90%4/28/2026 Zacks ResearchNot Rated UpgradeStrong Sell ➝ Hold3/30/2026 Barclays3 of 5 starsSaket Kalia2 of 5 starsLower TargetUnderweight$2.75 ➝ $1.00-9.50%2/27/2026 Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDavid HynesSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetHold$4.00 ➝ $3.00+142.91%2/27/2026 StephensSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingJeff GarroSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetEqual Weight$3.00 ➝ $2.00+65.29%1/21/2026 Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Reiterated RatingSell (D-)12/18/2025 Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingCraig HettenbachSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingUnderperform$3.50+53.51%11/6/2025 William BlairSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating UpgradeStrong-Buy8/8/2025 Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDavid GrossmanSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetBuy$5.00 ➝ $6.00+48.48%5/12/2025 The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingKash RanganSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetNeutral$3.00 ➝ $3.40-4.90% Get the Latest News and Ratings for DH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Definitive Healthcare and its competitors with MarketBeat's FREE daily newsletter. 5/9/2025 BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDavid LarsenSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeBuy ➝ Neutral1/16/2025 Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingRyan MacDonaldSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingHold8/9/2024 Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Lower TargetHold$7.00 ➝ $5.00+27.23%7/31/2024 JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating DowngradeNeutral ➝ Underweight$7.00 ➝ $5.00-12.89%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 02:46 AM ET. DH Forecast - Frequently Asked Questions What is Definitive Healthcare's forecast for 2026? According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Definitive Healthcare is $2.77, with a high forecast of $6.00 and a low forecast of $1.00. Should I buy or sell Definitive Healthcare stock right now? 8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Definitive Healthcare in the last twelve months. There are currently 3 sell ratings, 3 hold ratings, 1 buy rating and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" DH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DH, but not buy additional shares or sell existing shares. Does Definitive Healthcare's stock price have much upside? According to analysts, Definitive Healthcare's stock has a predicted upside of 224.65% based on their 12-month stock forecasts. Has Definitive Healthcare been upgraded or downgraded by Wall Street analysts recently? Over the previous 90 days, Definitive Healthcare's stock had 1 upgrade and 1 downgrade by analysts. What analysts cover Definitive Healthcare? Definitive Healthcare has been rated by research analysts at Barclays, Canaccord Genuity Group, Robert W. Baird, Stephens, and Zacks Research in the past 90 days. Do Wall Street analysts like Definitive Healthcare more than its competitors? Analysts like Definitive Healthcare less than other "computer and technology" companies. The consensus rating score for Definitive Healthcare is 2.00 while the average consensus rating score for "computer and technology" companies is 2.29. Learn more on how DH compares to other companies. Stock Forecasts and Research Tools Related Companies XPER Stock Forecast TBRG Stock Forecast ECX Stock Forecast SPT Stock Forecast ISSC Stock Forecast XNET Stock Forecast BLND Stock Forecast GRRR Stock Forecast SVCO Stock Forecast API Stock Forecast Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Brokerages With Definitive Healthcare RecommendationsRobert W. BairdZacks ResearchBarclaysWall Street ZenCanaccord Genuity GroupStephensWeiss RatingsMorgan StanleyWilliam BlairStifel Nicolaus This page (NASDAQ:DH) was last updated on 5/23/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Definitive Healthcare Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Definitive Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
